BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32674397)

  • 1. Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots.
    Auer-Grumbach M; Rettl R; Ablasser K; Agis H; Beetz C; Duca F; Gattermeier M; Glaser F; Hacker M; Kain R; Kaufmann B; Kovacs GG; Lampl C; Ljevakovic N; Nagele J; Pölzl G; Quasthoff S; Raimann B; Rauschka H; Reiter C; Skrahina V; Schuhfried O; Sunder-Plassmann R; Verheyen ND; Wanschitz J; Weber T; Windhager R; Wurm R; Zimprich F; Löscher WN; Bonderman D
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32674397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Hereditary Transthyretin-Related Amyloidosis Prevalence in Crete: Genetic Heterogeneity and Distinct Phenotypes.
    Tzagournissakis M; Foukarakis E; Samonakis D; Tsilimbaris M; Michaelidou K; Mathioudakis L; Marinis A; Giannakoudakis E; Spanaki C; Skoula I; Erimaki S; Amoiridis G; Koutsis G; Koukouraki S; Stylianou K; Plaitakis A; Mitsias PD; Zaganas I
    Neurol Genet; 2022 Oct; 8(5):e200013. PubMed ID: 36101541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
    Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
    J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
    Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
    Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L
    Coelho T; Ando Y; Benson MD; Berk JL; Waddington-Cruz M; Dyck PJ; Gillmore JD; Khella SL; Litchy WJ; Obici L; Monteiro C; Tai LJ; Viney NJ; Buchele G; Brambatti M; Jung SW; St L O'Dea L; Tsimikas S; Schneider E; Geary RS; Monia BP; Gertz M
    Neurol Ther; 2021 Jun; 10(1):375-389. PubMed ID: 33638113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Pharmacodynamics of Patisiran in Patients with hATTR Amyloidosis and with Polyneuropathy After Liver Transplantation.
    Badri P; Habtemariam B; Melch M; Clausen VA; Arum S; Li X; Jay PY; Vest J; Robbie GJ
    Clin Pharmacokinet; 2023 Oct; 62(10):1509-1522. PubMed ID: 37639169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare variant of transthyretin-related amyloidosis associated with exclusive cardiomyopathy in a Hong Kong Chinese patient.
    Wong CW; Ng WY; So KL; Chan YH; Yip SF; Mak CM
    J Cardiol Cases; 2018 Dec; 18(6):185-188. PubMed ID: 30595768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Frequency of V122I Transthyretin Mutation in a Cohort of African American Individuals With Bilateral Carpal Tunnel Syndrome.
    Shije JZ; Bautista MAB; Smotherman C
    Front Neurol; 2022; 13():949401. PubMed ID: 35959393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic heterogeneity of hereditary transthyretin amyloidosis in a sample of the Brazilian population.
    Lavigne-Moreira C; Marques VD; Gonçalves MVM; de Oliveira MF; Tomaselli PJ; Nunez JC; do Nascimento OJM; Barreira AA; Marques W
    J Peripher Nerv Syst; 2018 Jun; 23(2):134-137. PubMed ID: 29520877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records.
    Carry BJ; Young K; Fielden S; Kelly MA; Sturm AC; Avila JD; Martin CL; Kirchner HL; Fornwalt BK; Haggerty CM;
    JACC CardioOncol; 2021 Oct; 3(4):550-561. PubMed ID: 34746851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asp58Ala is the predominant mutation of the TTR gene in Korean patients with hereditary transthyretin-related amyloidosis.
    Jang MA; Lee GY; Kim K; Kim SJ; Kim JS; Lee SY; Kim HJ; Jeon ES
    Ann Hum Genet; 2015 Mar; 79(2):99-107. PubMed ID: 25644864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care.
    Luigetti M; Romano A; Di Paolantonio A; Bisogni G; Sabatelli M
    Ther Clin Risk Manag; 2020; 16():109-123. PubMed ID: 32110029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from the first-in-human in vivo CRISPR/Cas9 editing of the TTR gene by NTLA-2001 trial in patients with transthyretin amyloidosis with cardiomyopathy.
    Kotit S
    Glob Cardiol Sci Pract; 2023 Jan; 2023(1):e202304. PubMed ID: 37928601
    [No Abstract]   [Full Text] [Related]  

  • 19. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.